ESTABLISHEDSCIENCEscience-backed 100%

Wnt Signaling And Colorectal Cancer

Quality 80/100104 signals7 source typessince 2025-09-13

What is this

This trend focuses on the complex role of Wnt/β-Catenin signaling in colorectal cancer, emphasizing the interplay with post-transcriptional RNA regulation and associated molecular pathways. It highlights emerging research that links cellular signaling with cancer progression and potential therapeutic targets.

Why it matters

As colorectal cancer remains one of the most common and lethal cancers globally, new insights into its molecular drivers are crucial. Advances in understanding Wnt signaling now offer prospects for targeted therapies, driven by an increasing volume of high-quality research and clinical evidence.

Investment angle

Investors might look at biotech and pharmaceutical companies that are prioritizing targeted therapeutic approaches in colorectal cancer. Specific opportunities include investing in startups developing Wnt pathway modulators or established firms expanding their precision oncology pipelines.

Sovenyr read

A promising investment play in precision oncology with targeted biotech opportunities; Investability: 7/10.

History

Flagged 2025-09-13 · Status ESTABLISHED (since 2026-03-15) · last active 2026-07-28
2026-03-10signals (cumulative): 17 → 1042026-07-28
Y = cumulative signals, X = time. A steep climb means the cluster is actively growing; a flat or abruptly-ending line means momentum is gone.
datesignalsnewsubstance
2026-03-1017100%
2026-03-2159+42100%
2026-03-3163+4100%
2026-04-1266+3100%
2026-04-2268+2100%
2026-05-0374+6100%
2026-05-1581+7100%
2026-05-2686+5100%
2026-06-0589+3100%
2026-06-1693+4100%
2026-06-2694+1100%
2026-07-0798+4100%
2026-07-17102+4100%
2026-07-28104+2100%

Evidence

The 104 collected signals behind this trend — the 20 most recent, each linking to its primary source.
See the live dataTrack record